Jan de Kraker
Overview
Explore the profile of Jan de Kraker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink M, Acha T, Godzinski J, et al.
Lancet
. 2015 Jul;
386(9999):1156-64.
PMID: 26164096
Background: Before this study started, the standard postoperative chemotherapy regimen for stage II-III Wilms' tumour pretreated with chemotherapy was to include doxorubicin. However, avoidance of doxorubicin-related cardiotoxicity effects is important...
2.
Williams R, Chagtai T, Alcaide-German M, Apps J, Wegert J, Popov S, et al.
Oncotarget
. 2015 Mar;
6(9):7232-43.
PMID: 25749049
Genomic gain of the proto-oncogene transcription factor gene MYCN is associated with poor prognosis in several childhood cancers. Here we present a comprehensive copy number analysis of MYCN in Wilms...
3.
Wilde J, Aronson D, Sznajder B, van Tinteren H, Powis M, Okoye B, et al.
Pediatr Blood Cancer
. 2014 Aug;
61(12):2175-9.
PMID: 25156758
Background: Total nephrectomy (TN) remains the standard treatment of unilateral Wilms tumors (uWT). The SIOP WT-2001 protocol allowed Nephron Sparing Surgery (NSS) for polar or peripherally non-infiltrating tumors. Aim: Inventory...
4.
Bleeker G, Schoot R, Caron H, de Kraker J, Hoefnagel C, van Eck B, et al.
Eur J Nucl Med Mol Imaging
. 2013 Aug;
40(11):1711-7.
PMID: 23921531
Purpose: In the treatment of patients with high-risk neuroblastoma, different doses of (131)I-metaiodobenzylguanidine ((131)I-MIBG) are administered at different time points during treatment. Toxicity, mainly haematological (thrombocytopenia), from (131)I-MIBG therapy is...
5.
Schoot R, Bleeker G, Caron H, van Eck B, Heij H, de Kraker J, et al.
Eur J Nucl Med Mol Imaging
. 2013 Jun;
40(10):1516-22.
PMID: 23740371
Purpose: In patients with localised neuroblastoma without adverse genetic aberrations, observational treatment is justified. Therapy is required when organ or respiratory functions have become compromised. As the outcome is good,...
6.
Verschuur A, van Tinteren H, Graf N, Bergeron C, Sandstedt B, de Kraker J
J Clin Oncol
. 2012 Aug;
30(28):3533-9.
PMID: 22927531
Purpose: The purpose of this study was to determine the outcome of children with nephroblastoma and pulmonary metastases (PM) treated according to International Society of Pediatric Oncology (SIOP) 93-01 recommendations...
7.
Graf N, van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink M, Sandstedt B, et al.
Eur J Cancer
. 2012 Jul;
48(17):3240-8.
PMID: 22795263
Purpose: To determine the prognosis of children with stage II and III of low or intermediate risk histology (SIOP classification) in unilateral localised Wilms tumour (WT) after neoadjuvant chemotherapy according...
8.
Israels T, Borgstein E, Pidini D, Chagaluka G, de Kraker J, Kamiza S, et al.
J Pediatr Hematol Oncol
. 2012 Jul;
34(8):606-10.
PMID: 22767130
Wilms tumor has a survival rate of 85% to 90% in well-resourced countries. Malawi is a country in Sub-Saharan Africa with very limited resources. We evaluated the outcome of a...
9.
The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour
Israels T, Chagaluka G, Pidini D, Caron H, de Kraker J, Kamiza S, et al.
Pediatr Blood Cancer
. 2012 Jan;
59(4):636-41.
PMID: 22271712
Background: In Malawi, preoperative chemotherapy for Wilms tumour is a logical strategy, but detailed information on toxicity and efficacy in such a resource limited setting has been unavailable. Procedure: Patients...
10.
Segers H, van den Heuvel-Eibrink M, Pritchard-Jones K, Coppes M, Aitchison M, Bergeron C, et al.
Expert Rev Anticancer Ther
. 2011 Aug;
11(7):1105-13.
PMID: 21806333
Since Wilms' tumor occurs rarely in adults, there are no standard treatments available. Most adult patients will be diagnosed unexpectedly following nephrectomy for presumed renal cell carcinoma. Outcome for adults...